These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12000864)

  • 1. Murine dendritic cell-induced tumor apoptosis is partially mediated by nitric oxide.
    Shimamura H; Cumberland R; Hiroishi K; Watkins SC; Lotze MT; Baar J
    J Immunother; 2002; 25(3):226-34. PubMed ID: 12000864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.
    Huang J; Tatsumi T; Pizzoferrato E; Vujanovic N; Storkus WJ
    Cancer Res; 2005 Sep; 65(18):8461-70. PubMed ID: 16166326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.
    Saio M; Radoja S; Marino M; Frey AB
    J Immunol; 2001 Nov; 167(10):5583-93. PubMed ID: 11698429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses.
    Bonham CA; Lu L; Li Y; Hoffman RA; Simmons RL; Thomson AW
    Transplantation; 1996 Dec; 62(12):1871-7. PubMed ID: 8990379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
    Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
    Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CD4+ T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells.
    Wachter T; Averbeck M; Hara H; Tesmann JP; Simon JC; Termeer CC; Denfeld RW
    J Immunol; 2003 Jul; 171(2):776-82. PubMed ID: 12847245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
    Süss G; Shortman K
    J Exp Med; 1996 Apr; 183(4):1789-96. PubMed ID: 8666935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-γ and nitric oxide.
    Xu X; Yi H; Guo Z; Qian C; Xia S; Yao Y; Cao X
    J Immunol; 2012 Feb; 188(3):1168-77. PubMed ID: 22205032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.
    Lu L; Bonham CA; Chambers FG; Watkins SC; Hoffman RA; Simmons RL; Thomson AW
    J Immunol; 1996 Oct; 157(8):3577-86. PubMed ID: 8871658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.
    Pirtskhalaishvili G; Shurin GV; Gambotto A; Esche C; Wahl M; Yurkovetsky ZR; Robbins PD; Shurin MR
    J Immunol; 2000 Aug; 165(4):1956-64. PubMed ID: 10925278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.
    Tada Y; O-Wang J; Takiguchi Y; Tatsumi K; Kuriyama T; Okada S; Tokuhisa T; Sakiyama S; Tagawa M
    J Immunol; 2002 Sep; 169(5):2241-5. PubMed ID: 12193688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.
    Rescigno M; Piguet V; Valzasina B; Lens S; Zubler R; French L; Kindler V; Tschopp J; Ricciardi-Castagnoli P
    J Exp Med; 2000 Dec; 192(11):1661-8. PubMed ID: 11104808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways.
    Kuwashima N; Nishimura F; Eguchi J; Sato H; Hatano M; Tsugawa T; Sakaida T; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Gambotto A; Pollack IF; Storkus WJ; Okada H
    J Immunol; 2005 Aug; 175(4):2730-40. PubMed ID: 16081851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells.
    Fujita N; Kagamu H; Yoshizawa H; Itoh K; Kuriyama H; Matsumoto N; Ishiguro T; Tanaka J; Suzuki E; Hamada H; Gejyo F
    J Immunol; 2001 Nov; 167(10):5678-88. PubMed ID: 11698440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.